• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: A.I.D.D LONGFORD ARCHITECT TOTAL B-HCG REAGENT KIT; SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

A.I.D.D LONGFORD ARCHITECT TOTAL B-HCG REAGENT KIT; SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN Back to Search Results
Model Number 7K78-25
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/10/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Section a patient information: no further patient information was provided.
 
Event Description
The customer obtained a false negative architect total b-hcg result for a female patient diagnosed with an ectopic pregnancy.The following results were provided: (b)(6) 2020 sample id (b)(6): 36.32 miu/ml.(b)(6) 2020 sample id (b)(6): <1.20 miu/ml.(b)(6) 2020 sample id (b)(6): 23.82 miu/ml.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labelling review, device history record review, field data review and in house testing of retained kits with the complaint lot number.Return testing was not completed as returns were not available.Review of complaint activity and trending reports did not identify any issues or trends.Device history record review for the complaint lot did not identify any non-conformances or deviations.In house testing was performed using a retained kit of the complaint lot.All criteria were met indicating acceptable product performance.The overall performance of architect total b-hcg reagents in the field was reviewed using data gathered from customers worldwide.The median patient results of the positive population were within the acceptable, indicating the performance of the lot is acceptable.Based on our investigation, no systemic issue or deficiency of the architect total b-hcg reagent lot was identified.D4 expiration date changed from 01/25/2021 to 01/21/2021 due to an entry error.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT TOTAL B-HCG REAGENT KIT
Type of Device
SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN
Manufacturer (Section D)
A.I.D.D LONGFORD
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
MDR Report Key10895433
MDR Text Key228358941
Report Number3005094123-2020-00264
Device Sequence Number1
Product Code DHA
UDI-Device Identifier00380740014964
UDI-Public00380740014964
Combination Product (y/n)N
PMA/PMN Number
K983424
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/24/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/21/2021
Device Model Number7K78-25
Device Catalogue Number07K78-25
Device Lot Number12124UI00
Was Device Available for Evaluation? No
Date Manufacturer Received01/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I1000SR MOD, 01L86-01, I1SR03859; ARC I1000SR MOD, 01L86-01, I1SR03859
-
-